| Shivakeerthy S Ubranimath, MD | |
|
100 Woods Rd, Valhalla, NY 10595-1530 | |
| (914) 493-7000 | |
| (914) 493-8439 |
| Full Name | Shivakeerthy S Ubranimath |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 36 Years |
| Location | 100 Woods Rd, Valhalla, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093742520 | NPI | - | NPPES |
| 02387415 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 226202 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Westchester Medical Center | Valhalla, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Westchester Medical Center Advanced Physician Services Pc | 3173660776 | 729 |
News Archive
Physician-scientists at Memorial Sloan-Kettering Cancer Center are studying a novel approach to treat metastatic melanoma, known as immunotherapy, which uses the body's own immune system to attack cancer. Presented today at the American Society of Clinical Oncology annual meeting, encouraging new data shows - for the first time - a survival benefit in metastatic melanoma patients using an immunotherapy discovered and clinically investigated by researchers at Memorial Sloan-Kettering.
A single, upfront genomic test is more effective for detecting Lynch syndrome in colorectal cancer (CRC) patients than the traditional multiple, sequential testing approach, according to new clinical data reported by The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Actavis plc, a leading global specialty pharmaceutical company today announced that it has acquired Silom Medical Company, a privately held generic pharmaceutical company focused on developing and marketing therapies in Thailand, for approximately $100 million in cash.
The news about the novel coronavirus in China grows more urgent daily. The number of related deaths is now greater than 1,300, while tens of thousands of people have been infected — most of them in China. People returning to the U.S. from China are quarantined for 14 days.
Patients with sepsis, one of the most time-sensitive and hard-to-detect illnesses in medicine, are more likely to survive the life-threatening condition when treated at a hospital that sees a higher volume of sepsis cases.
› Verified 4 days ago
| Entity Name | Westchester Medical Center Advanced Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912131392 PECOS PAC ID: 3173660776 Enrollment ID: O20091031000042 |
News Archive
Physician-scientists at Memorial Sloan-Kettering Cancer Center are studying a novel approach to treat metastatic melanoma, known as immunotherapy, which uses the body's own immune system to attack cancer. Presented today at the American Society of Clinical Oncology annual meeting, encouraging new data shows - for the first time - a survival benefit in metastatic melanoma patients using an immunotherapy discovered and clinically investigated by researchers at Memorial Sloan-Kettering.
A single, upfront genomic test is more effective for detecting Lynch syndrome in colorectal cancer (CRC) patients than the traditional multiple, sequential testing approach, according to new clinical data reported by The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Actavis plc, a leading global specialty pharmaceutical company today announced that it has acquired Silom Medical Company, a privately held generic pharmaceutical company focused on developing and marketing therapies in Thailand, for approximately $100 million in cash.
The news about the novel coronavirus in China grows more urgent daily. The number of related deaths is now greater than 1,300, while tens of thousands of people have been infected — most of them in China. People returning to the U.S. from China are quarantined for 14 days.
Patients with sepsis, one of the most time-sensitive and hard-to-detect illnesses in medicine, are more likely to survive the life-threatening condition when treated at a hospital that sees a higher volume of sepsis cases.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shivakeerthy S Ubranimath, MD 100 Woods Rd, Valhalla, NY 10595-1530 Ph: (914) 493-7000 | Shivakeerthy S Ubranimath, MD 100 Woods Rd, Valhalla, NY 10595-1530 Ph: (914) 493-7000 |
News Archive
Physician-scientists at Memorial Sloan-Kettering Cancer Center are studying a novel approach to treat metastatic melanoma, known as immunotherapy, which uses the body's own immune system to attack cancer. Presented today at the American Society of Clinical Oncology annual meeting, encouraging new data shows - for the first time - a survival benefit in metastatic melanoma patients using an immunotherapy discovered and clinically investigated by researchers at Memorial Sloan-Kettering.
A single, upfront genomic test is more effective for detecting Lynch syndrome in colorectal cancer (CRC) patients than the traditional multiple, sequential testing approach, according to new clinical data reported by The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Actavis plc, a leading global specialty pharmaceutical company today announced that it has acquired Silom Medical Company, a privately held generic pharmaceutical company focused on developing and marketing therapies in Thailand, for approximately $100 million in cash.
The news about the novel coronavirus in China grows more urgent daily. The number of related deaths is now greater than 1,300, while tens of thousands of people have been infected — most of them in China. People returning to the U.S. from China are quarantined for 14 days.
Patients with sepsis, one of the most time-sensitive and hard-to-detect illnesses in medicine, are more likely to survive the life-threatening condition when treated at a hospital that sees a higher volume of sepsis cases.
› Verified 4 days ago
Karen Francois, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7000 | |
Dr. John Andrew Cooley, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 814-493-7000 Fax: 703-766-9725 | |
Dr. Debra Lederman, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7000 Fax: 914-493-7927 | |
Nenna Nwazota, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-2844 | |
Dr. Saman Yaghoubian, D.O Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7000 Fax: 914-493-7927 | |
Dr. Paul Young Mah, Anesthesiology Medicare: Medicare Enrolled Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7000 |